Home blood-pressure monitoring in patients receiving sunitinib

被引：155

作者：

Azizi, Michel ^{[1
]}

Chedid, Antoine ^{[1
]}

Oudard, Stephane ^{[1
]}

机构：

[1] Hop Europeen Georges Pompidou, F-75015 Paris, France

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 01期

关键词：

D O I：

10.1056/NEJMc072330

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：95 / 97

页数：3

相关论文

共 6 条

[1] Sunitinib: From rational design to clinical efficacy
Chow, Laura Q. M.
Eckhardt, S. Gail
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 884 - 896
[2] Hypertension and targeted therapy Part 2: Small molecule inhibitors of VEGF
Chowdhury, Simon
Spicer, James F.
Harper, Peter G.
[J]. TARGETED ONCOLOGY, 2006, 1 (03) : 172 - 178
[3] Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]
[4] 2007 Guidelines for the Management of Arterial Hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology (vol 25, pg 1105, 2007)
Mancia, Giuseppe
[J]. JOURNAL OF HYPERTENSION, 2007, 25 (08) : 1749 - 1749
[5] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Motzer, Robert J.
Hutson, Thomas E.
Tomczak, Piotr
Michaelson, M. Dror
Bukowski, Ronald M.
Rixe, Olivier
Oudard, Stephane
Negrier, Sylvie
Szczylik, Cezary
Kim, Sindy T.
Chen, Isan
Bycott, Paul W.
Baum, Charles M.
Figlin, Robert A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 115 - 124
[6] Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis
Zhu, Xiaolei
Wu, Shenhong
Dahut, William L.
Parikh, Chirag R.
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (02) : 186 - 193